Long-Term K+ Channel-Mediated Dampening of Dopamine Neuron Excitability by the Antipsychotic Drug Haloperidol

Antipsychotic drugs require days of treatment to begin to produce therapeutic effects. We report that in vivo treatment with the antipsychotic drug haloperidol acts with a delay of days to slow spontaneous repetitive firing by isolated midbrain dopamine neurons. The decreased excitability is caused by an increased number of functional A-type K+ channels without any change in gating properties. Upregulation of dopamine neuron Kv4.3 mRNA accounts for this effect, demonstrating a role for channel gene expression in this delayed drug action. The resultant long-term dampening of dopamine neuron excitability may serve to tone down the dopamine system.

[1]  M. Jiang,et al.  Reverse use dependence of Kv4.2 blockade by 4-aminopyridine. , 1996, The Journal of pharmacology and experimental therapeutics.

[2]  Martin H. Teicher,et al.  Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. , 1988, Archives of general psychiatry.

[3]  G. Gessa,et al.  Failure of chronic haloperidol to induce depolarization inactivation of dopamine neurons in unanesthetized rats. , 1994, European journal of pharmacology.

[4]  J. Barker,et al.  Postnatal rat nigrostriatal dopaminergic neurons exhibit five types of potassium conductances. , 1990, Journal of neurophysiology.

[5]  H. Meltzer,et al.  Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. , 1991, The Journal of pharmacology and experimental therapeutics.

[6]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[7]  T. Crow,et al.  MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA , 1978, The Lancet.

[8]  F. Ashcroft,et al.  Identification and electrophysiology of isolated pars compacta neurons from guinea-pig substantia nigra , 1991, Neuroscience.

[9]  H. Meltzer,et al.  Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment , 1990, Brain Research.

[10]  G. Gessa,et al.  Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats , 1998, Brain Research.

[11]  S. Cragg,et al.  Dopamine Release and Uptake Dynamics within Nonhuman Primate Striatum In Vitro , 2000, The Journal of Neuroscience.

[12]  Anthony A. Grace,et al.  Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs , 1997, Trends in Neurosciences.

[13]  P. Vargiu,et al.  Depolarization inactivation of dopamine neurons: an artifact? , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  C. Stevens,et al.  Voltage clamp studies of a transient outward membrane current in gastropod neural somata , 1971, The Journal of physiology.

[15]  D. Brooks The role of the basal ganglia in motor control: contributions from PET , 1995, Journal of the Neurological Sciences.

[16]  P. Seeman,et al.  Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.

[17]  B. Bean,et al.  Voltage-dependent calcium channels in rat midbrain dopamine neurons: modulation by dopamine and GABAB receptors. , 1995, Journal of neurophysiology.

[18]  K. Takimoto,et al.  Independent Regulation of Cardiac Kv4.3 Potassium Channel Expression by Angiotensin II and Phenylephrine , 2001, Circulation research.

[19]  G. Westbrook,et al.  Regulation of synaptic timing in the olfactory bulb by an A-type potassium current , 1999, Nature Neuroscience.

[20]  Steven W. Johnson,et al.  GDNF acutely modulates excitability and A-type K+ channels in midbrain dopaminergic neurons , 2001, Nature Neuroscience.

[21]  N. Spruston,et al.  Diversity and dynamics of dendritic signaling. , 2000, Science.

[22]  F. J. White,et al.  Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.

[23]  S. Snyder,et al.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. , 1976, Science.

[24]  S. Thompson Three pharmacologically distinct potassium channels in molluscan neurones. , 1977, The Journal of physiology.

[25]  R. Volkmann,et al.  Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. , 1997, Molecular pharmacology.

[26]  B. Liss,et al.  Tuning pacemaker frequency of individual dopaminergic neurons by Kv4.3L and KChip3.1 transcription , 2001, The EMBO journal.

[27]  F. Weiss,et al.  The dopamine hypothesis of reward: past and current status , 1999, Trends in Neurosciences.

[28]  D. Johnston,et al.  K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons , 1997, Nature.

[29]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[30]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: single spike firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  J. Barker,et al.  5,7-Dihydroxytryptamine identifies living dopaminergic neurons in mesencephalic cultures. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. V. Van Heertum,et al.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I B Levitan,et al.  Serotonin acting via cyclic AMP enhances both the hyperpolarizing and depolarizing phases of bursting pacemaker activity in the Aplysia neuron R15 , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  N. Castle,et al.  Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes. , 1993, The Journal of pharmacology and experimental therapeutics.

[35]  S. Heckers,et al.  Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia , 2001, Biological Psychiatry.

[36]  P. Seeman,et al.  Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E Marder,et al.  Memory from the dynamics of intrinsic membrane currents. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. J. White,et al.  Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. , 1983, Life sciences.

[39]  B. Bunney,et al.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.